Evaluation of revised classification criteria for giant cell arteritis and its clinical phenotypes.
classification criteria
giant cell arteritis
phenotypes
Journal
Rheumatology (Oxford, England)
ISSN: 1462-0332
Titre abrégé: Rheumatology (Oxford)
Pays: England
ID NLM: 100883501
Informations de publication
Date de publication:
24 12 2021
24 12 2021
Historique:
pubmed:
20
4
2021
medline:
23
2
2022
entrez:
19
4
2021
Statut:
ppublish
Résumé
GCA is a systemic vasculitis of the elderly, viewed by many as a disease with multiple and overlapping clinical phenotypes. Retrospective studies have shown differences in clinical presentation between these phenotypes. To reflect the heterogeneity of GCA and novel diagnostic methods, new classification criteria have been proposed. This is a retrospective study of newly diagnosed patients with GCA at the outpatient rheumatology clinics at Skåne University Hospital (Malmö and Lund) between 2012 and 2018. All patients were evaluated using two sets of classification criteria, the ACR classification criteria from 1990 and a proposed revision of these criteria requiring objective findings (positive biopsy or imaging) for classification. Patients were further classified as one of four widely used clinical phenotypes. A total of 183 patients with a new diagnosis of GCA were identified. The diagnosis was confirmed by one or two experienced rheumatologists in 116 of these patients during a review of medical records. The ACR criteria were more sensitive than the revised criteria (93.1% vs 72.4%), but the revised criteria had higher specificity (94.0% vs 28.4%). The revised criteria tended to have higher sensitivity in the phenotype with constitutional symptoms compared with cranial GCA (P = 0.08). The specificity of the ACR classification criteria for GCA can be improved by using revised criteria requiring objective findings of vasculitis. In addition, the wider symptoms covered by the revised criteria may improve classification of patients with a phenotype characterized by constitutional symptoms.
Sections du résumé
BACKGROUND
GCA is a systemic vasculitis of the elderly, viewed by many as a disease with multiple and overlapping clinical phenotypes. Retrospective studies have shown differences in clinical presentation between these phenotypes. To reflect the heterogeneity of GCA and novel diagnostic methods, new classification criteria have been proposed.
METHODS
This is a retrospective study of newly diagnosed patients with GCA at the outpatient rheumatology clinics at Skåne University Hospital (Malmö and Lund) between 2012 and 2018. All patients were evaluated using two sets of classification criteria, the ACR classification criteria from 1990 and a proposed revision of these criteria requiring objective findings (positive biopsy or imaging) for classification. Patients were further classified as one of four widely used clinical phenotypes.
RESULTS
A total of 183 patients with a new diagnosis of GCA were identified. The diagnosis was confirmed by one or two experienced rheumatologists in 116 of these patients during a review of medical records. The ACR criteria were more sensitive than the revised criteria (93.1% vs 72.4%), but the revised criteria had higher specificity (94.0% vs 28.4%). The revised criteria tended to have higher sensitivity in the phenotype with constitutional symptoms compared with cranial GCA (P = 0.08).
CONCLUSION
The specificity of the ACR classification criteria for GCA can be improved by using revised criteria requiring objective findings of vasculitis. In addition, the wider symptoms covered by the revised criteria may improve classification of patients with a phenotype characterized by constitutional symptoms.
Identifiants
pubmed: 33871583
pii: 6237931
doi: 10.1093/rheumatology/keab353
pmc: PMC8742823
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
383-387Informations de copyright
© The Author(s) 2021. Published by Oxford University Press on behalf of the British Society for Rheumatology.
Références
Clin Exp Rheumatol. 2019 Mar-Apr;37 Suppl 117(2):57-60
pubmed: 31162029
Int J Rheum Dis. 2019 Jan;22 Suppl 1:21-27
pubmed: 29707909
Rheumatology (Oxford). 2017 Apr 1;56(4):506-515
pubmed: 27481272
Semin Arthritis Rheum. 2020 Oct;50(5):1040-1048
pubmed: 32911281
Medicine (Baltimore). 2016 Jun;95(26):e3818
pubmed: 27367984
Clin Exp Nephrol. 2013 Oct;17(5):619-621
pubmed: 23996327
Arthritis Rheum. 1990 Aug;33(8):1122-8
pubmed: 2202311
Ann Rheum Dis. 2020 Jan;79(1):19-30
pubmed: 31270110
Arthritis Rheum. 2013 Jan;65(1):1-11
pubmed: 23045170
Eur J Intern Med. 2005 Jun;16(3):183-186
pubmed: 15967333
Rheumatology (Oxford). 2020 May 1;59(5):1011-1020
pubmed: 31529073
Scand J Rheumatol. 2019 Jul;48(4):259-265
pubmed: 30838907